Tauopathy Challenge Workshop Grant

The Tauopathy Challenge Workshop, hosted by the Rainwater Charitable Foundation, aims to bridge critical gaps in the understanding of copathologies associated with primary tauopathies. Up to 12 participants will be selected through a competitive Letter of Intent process, each receiving a $10,000 grant. Following the workshop, attendees can apply for research grants of up to $500,000 over two years, fostering innovative research in neurodegeneration.

NOTE:
Workshop participants will be selected through a competitive Letter of Intent (LOI) process. Through the LOI process, up to 12 participants will be selected by the RCF to attend the workshop and each attendee will receive a $10,000 grant to support their laboratory research. Travel and lodging expenses will also be covered.Following the meeting, workshop attendees can apply for research grants providing up to $500,000 over two years; up to four awards will be funded, pending budget availability.
The Rainwater Charitable Foundation (RCF), along with our partners CurePSP and the Aging Mind Foundation, is pleased to announce the second Tauopathy Challenge WorkshopTM that will focus on addressing key gaps in our understanding of copathologies that are often present with the primary tauopathies.
The presence of copathologies can complicate diagnosis and therapeutic development for the primary tauopathies. There is a need for the research field to understand how aggregate-forming proteins like tau propagate in the brain, and how those pathological species derive from, instigate the formation of, or interact with other pathologies.
Funding
Workshop Participation Grant Amount: $10,000 / invited participant
Post-workshop Research Grant Amount: $500,000 direct costs over 2 years. No indirect costs allowed.

Eligibility

The LOI will be used to identify novel ideas from researchers with diverse insights to solve key gaps in our understanding of the mechanisms of copathology with a focus on primary tauopathies (i.e., Pick’s disease, progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease, globular glial tauopathy, aging-related tau astrogliopathy, and frontotemporal dementias).

Ineligibility

Please note that LOIs solely studying the role of amyloid beta (Aβ) and tau interaction will not be considered.